New radiotherapy strategy improves survival for lung cancer patients

Study results presented at the 39th annual meeting for the American Society of Clinical Oncology (ASCO) by Chandra P. Belani, M.D., professor of medicine, University of Pittsburgh and co-director, Lung Cancer Program, University of Pittsburgh Cancer Institute (UPCI), demonstrate that a new therapeutic radiation strategy for non-small cell lung cancer (NSCLC) – the most common form of the disease – leads to improved survival for lung cancer patients with locally advanced disease.

n the study, hyperfractionated accelerated radiotherapy (HART) was compared to standard thoracic radiotherapy following chemotherapy. HART is a strategy in which radiation is administered frequently over a shorter period of time for two and a half weeks compared to seven weeks.

The phase III multi-site study compared HART to standard radiation therapy in 119 patients with unresectable stage III NSCLC. The patients were randomized into the two groups following two cycles of chemotherapy. Results indicated a median survival of 21 months for patients who received chemotherapy followed by HART, compared to a median survival of 12 months for patients who received chemotherapy followed by standard radiation therapy. One, two and three-year survival rates were 60 percent, 37 percent and 23 percent respectively in the HART group compared to one, two and three-year survival rates of 52 percent, 28 percent and 15 percent in the standard radiation therapy group.

“We found that chemotherapy followed by HART was an effective treatment strategy that was well tolerated by patients enrolled in the trial,” said Dr. Belani, lead investigator of the study. “These data provide further verification that shortening the duration of radiation treatment may be an important therapeutic strategy for locally advanced NSCLC.”

Non-small cell lung cancer is the most common type of lung cancer, accounting for almost 80 percent of lung cancers.

CONTACT:
Clare Collins
Jocelyn Uhl
PHONE: (412) 647-3555
FAX: (412) 624-3184
E-MAIL:
CollCX@upmc.edu
UhlJH@upmc.edu

Media Contact

Clare Collins EurekAlert!

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors